The leading organization in the U.S. dedicated to addressing lupus, The Lupus Foundation of America, has just revealed the recipients of five research grants, awarded under the Foundation’s commitment to support lupus-focused researchers in conducting clinical trials necessary to better understanding and eventually curing this life-altering autoimmune disease. “The researchers…
A history of thrombocytopenia is a strong predictor of diffuse alveolar haemorrhage (DAH) in patients with systemic lupus erythematosus, according to the results of a recent study published in the journal Lupus, Science & Medicine. Systemic lupus erythematosus (SLE) is an autoimmune disease in…
In a recent study entitled “Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival” researchers performed the first study investigating the risk factors for diffuse alveolar haemorrhage in systemic lupus erythematosus and how it impacts patients’ therapy responses and outcomes. The study was published…
A recent study funded by the NIH/NIAMS, revealed data that will lead to a further understanding of why pregnant women with systemic lupus erythematosus (SLE) are at higher risk for adverse pregnancy outcomes (APO), including preeclampsia, placental insufficiency, fetal death, miscarriages, and other complications. The study entitled, “Biomarkers Measured…
In a recent study, researchers from University Hospital of Split, Croatia investigated the relationship between Vitamin D, Interferon-gamma (INF-gamma) and Estradiol in females of childbearing age with inactive Systemic Lupus Erythematosus (SLE). The paper entitled “Relationship between vitamin D, IFN-c, and E2 levels in systemic lupus erythematosus” was…
In a recent study entitled “Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus” scientists discovered that the biggest human γδ T cell subset, the Vδ2 T cells present in peripheral blood, are key mediators of tissue injury…
Studies have revealed there is a gap between what lupus patients experience and what they tell their clinicians with results from a recent survey showing that closing this gap may lead to better communication and improved clinical management of the disease. The 2014 online survey funded and developed by GSK included 905 global respondents…
Sandra C. Raymond, President and CEO of the Lupus Foundation of America joined U.S. Representative Robin Kelly (D-IL), of Illinois’ 2nd Congressional District and Chair of the Congressional Black Caucus (CBC) Health Braintrust at an event Friday, September 18 to release official Congressional analysis of the state of African…
A team of researchers from Brazil and Israel review in a recent paper the evidences linking systemic lupus erythematosus and periodontal disease. The study entitled “Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by Toll-Like Receptors-2 and 4 (TLR2, TLR4)” was published in the…
The Alliance for Lupus Research (ALR), a national volunteer health organization dedicated to finding better treatments and ultimately preventing and cure systemic lupus erythematosus (SLE, or lupus) has contributed more than $100 million to research and development for SLE. ALR recently sponsored New York Jets guard Willie Colon’s 1st Annual…
